Investors


Financial and regulatory information

2025 Financial calendar


2024 Fourth quarter January 2025
2024 Year-end results April 2025
2025 Half-year results October 2025

NCX 470 (bimatoprost grenod) – Mont Blanc Data and Value Proposition

NCX 470 (bimatoprost grenod) – Denali Phase 3 Study Topline Results

Regulatory information

This section contains information provided for under article 221-1 of the Règlement général de l’AMF.


Voting rights

This section contains information provided for under article 221-1 of the AMF General Regulation
Older documents